Raymond James & Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
NI
Raymond James & Associates's QGEN Position: Q3 2024 in Review
Raymond James & Associates reduced its Qiagen (QGEN) stake by 63% in Q3 2024, selling an estimated $15.2M and leaving 193,218 shares worth $9.06M. The position accounts for 0.01% of the portfolio, ranked #1284.
Raymond James & Associates first reported a position in QGEN in Q4 2019 and has held it in 19 quarters since. The position peaked at $22.3M in Q2 2024. 329 funds tracked by Wall St. Rank hold QGEN as of Q3 2024.
- Raymond James & Associates held 193,218 shares of Qiagen worth $9.06M as of Q3 2024.
- Raymond James & Associates sold 334,167 Qiagen shares in Q3 2024, an estimated $15.2M.
- Qiagen made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1284 holding.
- Raymond James & Associates first reported a position in Qiagen in Q4 2019 and has held it in 19 quarters since.
- Raymond James & Associates's Qiagen position peaked at $22.3M in Q2 2024.
- 329 funds tracked by Wall St. Rank held Qiagen as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.